Success Stories: EB-1A Approved for Postdoctoral Associate in Massachusetts in the Field of Oral Immunology
On January 8th, 2015, We Received Another EB1-A (Alien of Extraordinary Ability) Approval for a Postdoctoral Associate in the Field of Oral Immunology (Approval Notice)
Position at the Time of Case Filing: Postdoctoral Associate
Country of Origin: China
Service Center: Texas Service Center (TSC)
Country of Residence at the Time of Filing: Massachusetts
Approval Notice Date: January 8th, 2015
Processing Time: 28 Days (16 Days after Premium Processing Requested)
In this case, the client that we had the opportunity to work with was a Postdoctoral Associate from China in the field of Oral Immunology. Her specialized research has focused on obesity and periodontal diseases (gum diseases) to study their role in Type-2 Diabetes. Her work had resulted in 5 highly-cited peer-reviewed scientific articles and numerous presentations at national and international conferences; at the time that her case was filed, her publications had been cited at least 114 times by independent and leading researchers from prestigious institutions and organizations around the world, indicating the major significance of her work. She had also reviewed 33 manuscripts for distinctive, internationally-circulated journals. Her superior level of expertise was confirmed in the following quote from an independent recommender, “[Client] has inferred that periodontal disease exhibits a radically different pathogenesis in obese individuals compared to lean individuals and, therefore, the treatments for inflammatory bone disease are different for each group; a B-cell manipulation can negate the effects of periodontal disease for an individual with Type 2 Diabetes, but this treatment would have no effect for a patient without Type 2 Diabetes.” It was our goal to prove that our client qualified for classification as an Alien of Extraordinary Ability given that she sought to remain in the United States to continue work in the area of Oral Immunology, and that her continued research would substantially and prospectively benefit the United States. With the proof and documentation that we provided, her case was approved in 28 days.